A phase 1 trial of romidepsin, azacitidine, dexamethasone, and lenalidomide in relapsed or refractory T-cell lymphoma.
Saved in:
| Title: | A phase 1 trial of romidepsin, azacitidine, dexamethasone, and lenalidomide in relapsed or refractory T-cell lymphoma. |
|---|---|
| Authors: | Gordon MJ; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Miljkovic MD; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.; Cartesian Therapeutics, Gaithersburg, MD., Milhon P; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Lakhotia R; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Melani C; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Johnson K; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Bryant B; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Jaffe ES; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Conlon K; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Staudt LM; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Wilson WH; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Roschewski M; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Ng S; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD. |
| Source: | Blood advances [Blood Adv] 2026 May 26; Vol. 10 (10), pp. 3398-3408. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
